Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Platelet-rich Plasma Versus Platelet-rich Plasma Plus Concentrated Insulin-like Growth Factor for Patellar Tendinosis: a Randomized Comparative Trial

NCT04350827 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT04350827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04350827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Platelet-rich Plasma Versus Platelet-rich Plasma Plus Concentrated Insulin-like Growth Factor for Patellar Tendinosis: a Randomized Comparative Trial
Lead sponsor
Ohio State University
Phase
Not applicable
Overall status
Completed
Start date
February 25, 2020
Completion date
October 16, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patellar ligament, platelet-rich plasma, tendinopathy